Dec 23, 2025 01:29PM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 5, 2025 08:02AM Amneal reports positive interim results for Parkinson's drug CREXONT
Dec 5, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 1, 2025 04:01PM
Dec 1, 2025 04:01PM
Nov 13, 2025 04:01PM
Nov 13, 2025 04:01PM Amneal Receives U.S. FDA Approval for Iohexol Injection
Oct 30, 2025 06:00AM
Oct 29, 2025 04:09PM
Oct 29, 2025 04:05PM
Oct 27, 2025 08:00AM
Oct 6, 2025 08:00AM
Sep 26, 2025 08:02AM
Sep 26, 2025 08:00AM Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
Sep 23, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 4, 2025 04:01PM
Sep 4, 2025 04:01PM
Aug 5, 2025 06:00AM Amneal Reports Second Quarter 2025 Financial Results
Jul 21, 2025 07:40AM
Jul 21, 2025 07:38AM
Jun 25, 2025 08:04AM
Jun 25, 2025 08:00AM
Jun 12, 2025 08:01AM
Jun 12, 2025 08:00AM
May 15, 2025 08:00AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Brekiya
May 15, 2025 08:00AM
May 8, 2025 07:00AM
Apr 11, 2025 08:00AM
Apr 7, 2025 08:00AM
Apr 7, 2025 08:00AM
Apr 3, 2025 08:01AM
Apr 3, 2025 08:00AM Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.
Mar 3, 2025 04:10PM
Mar 3, 2025 04:05PM
Feb 19, 2025 08:00AM
Feb 19, 2025 08:00AM
Jan 23, 2025 08:01AM
Jan 23, 2025 08:00AM
Nov 21, 2024 04:07PM Amneal Pharmaceuticals (AMRX) Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
Nov 21, 2024 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All